Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions

Cell

Volumn 93, Issue 2, 1998, Pages 203-214

  Shmerling, Doron ^d   Hegyi, Ivan ^b   Fischer, Marek ^c   Blättler, Thomas ^b   Brandner, Sebastian ^b   Götz, Jürgen ^a   Rülicke, Thomas ^c   Flechsig, Eckhard ^a   Cozzio, Antonio ^a   Von Mering, Christian ^a   Hangartner, Christoph ^a   Aguzzi, Adriano ^b   Weissmann, Charles ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; PRION PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; CEREBELLUM DISEASE; CONTROLLED STUDY; GRANULE CELL; KNOCKOUT MOUSE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCRAPIE; TRANSGENE;

ANIMALIA; ATAXIA;

EID: 0001552281     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81572-X     Document Type: Article

References (45)

1. Barry, R.A., Vincent, M.T., Kent, S.B., Hood, L.E., and Prusiner, S.B. (1988). Characterization of prion proteins with monospecific antisera to synthetic peptides. J. Immunol. 140, 1188-1193.
2. Bendheim, P.E., Brown, H.R., Rudelli, R.D., Scala, L.J., Goller, N.L., Wen, G.Y., Kascsak, R.J., Cashman, N.R., and Bolton, D.C. (1992). Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42, 149-156.
3. Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A. (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343.
4. Brinster, R.L., Chen, H.Y., Trumbauer, M.E., Yagle, M.K., and Palmiter, A.D. (1985). Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc. Natl. Acad. Sci. USA 82, 4438-4442.
5. Brown, D.R., Qin, K., Herms, J.W., Madlung, A., Manson, J., Strome, R., Fraser, P.E., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W., et al. (1997). The cellular prion protein binds copper in vivo. Nature 390, 684-687.
6. Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S.J., Prusiner, S.B., Aguet, M., and Weissmann, C. (1992). Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582.
7. Chen, S.G., Teplow, D.B., Parchi, P., Teller, J.K., Gambetti, P., and Autilio-Gambetti, L. (1995). Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173-19180.
8. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Colling, S.B., Collinge, J., and Jefferys, J.G. (1996). Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci. Lett. 209, 49-52.
10. Collinge, J., Whittington, M.A., Sidle, K.C.L., Smith, C.J., Palmer, M.S., Clarke, A.R., and Jefferys, J.G.R. (1994). Prion protein is necessary for normal synaptic function. Nature 370, 295-297.
11. Donne, D.G., Viles, J.H., Groth, D., Mehlhorn, I., James, T.L., Cohen, F.E., Prusiner, S.B., Wright, P.E., and Dyson, H.J. (1997). Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94, 13452-13457.
12. o/o mice with novel wild-type and mutant transgenes. University of Zürich, Zürich, Switzerland.
13. Fischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., Brandner, S., Aguzzi, A.L, and Weissmann, C. (1996). Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264.
14. Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J.M. (1985). Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13, 1431-1442.
15. Haltia, M., and Somer, M. (1993). Infantile cerebello-optic atrophy. Neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia and optic atrophy (the PEHO syndrome). Acta Neuropathol. 85, 241-247.
16. Harris, D.A., Huber, M.T., van Dijken, P., Shyng, S.L., Chait, B.T., and Wang, R. (1993). Processing of a cellular prion protein: identification of N-and C-terminal cleavage sites. Biochemistry 32, 1009-1016.
17. Herms, J.W., Kretzschmar, H.A., Titz, S., and Keller, B.U. (1995). Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur. J. Neurosci. 7, 2508-2512.
18. Hsiao, K.K., Groth, D., Scott, M., Yang, S.L., Serban, H., Rapp, D., Foster, D., Torchia, M., Dearmond, S.J., and Prusiner, S.B. (1994). Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91, 9126-9130.
19. Lledo, P.-M., Tremblay, P., DeArmond, S.J., Prusiner, S.B., and Nicoll, R.A. (1996). Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. USA 93, 2403-2407.
20. Manson, J.C., Clarke, A.R., Hooper, M.L., Aitchison, L., McConnell, I., and Hope, J. (1994). 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8, 121-127.
21. Martins, V.R., Graner, E., Garcia-Abreu, J., de Souza, S.J., Mercadante, A.F., Veiga, S.S., Zanata, S.M., Moura Neto, V., and Brentani, R.R. (1997). Complementary hydropathy identifies a cellular prion priotein receptor. Nat. Med. 3, 1376-1382.
22. McAndrew, J., Paterson, A.J., Asa, S.I., McCarthy, K.J., and Kudlow, J.E. (1995). Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136, 4479-4488.
23. McKusick, V.A. (1988). Mendelian Inheritance in Man (Baltimore, MD: The Johns Hopkins University Press).
24. Muramoto, T., DeArmond, S.J., Scott, M., Telling, G.C., Cohen, F.E., and Prusiner, S.B. (1997). Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat. Med. 3, 750-755.
25. Norman, R.M. (1940). Primary degeneration of the granular layer of the cerebellum: an unusual form of familial cerebellar atrophy occurring in early life. Brain 63, 365-379.
26. Oesch, B., Westaway, D., Wälchli, M., McKinley, M.P., Kent, S.B., Aebersold, R., Barry, R.A., Tempst, P., Teplow, D.B., Hood, L.E., et al. (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
27. Pascual-Castroviejo, I., Gutierrez, M., Morales, C., Gonzalez-Mediero, I., Martinez-Bermejo, A., and Pascual-Pascual, S.I. (1994). Primary degeneration of the granular layer of the cerebellum. A study of 14 patients and review of the literature. Neuropediatrics 25, 183-190.
28. Petty, K.J. (1996). Metal chelate affinity chromatography. In Current Protocols in Protein Science, J.E. Coligan, B.M. Dunn, H.L. Ploegh, D.W. Speicher, and P.T. Wingfield, eds. (New York: John Wiley and Sons), pp. 9.4.1-9.4.16.
29. Prusiner, S.B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
30. Rieger, R., Edenhofer, F., Lasmézas, C.I., and Weiss, S. (1997). The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383-1388.
31. Riek, R., Hornemann, S., Wider, G., Glockshuber, R., and Wüthrich, K. (1997). NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 413, 282-288.
32. Sakaguchi, S., Katamine, S., Shigematsu, K., Nakatani, A., Moriuchi, R., Nishida, N., Kurokawa, K., Nakaoke, R., Sato, H., Jishage, K., et al. (1995). Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent. J. Virol. 69, 7586-7592.
33. Sakaguchi, S., Katamine, S., Nishida, N., Moriuchi, R., Shigematsu, K., Sugimoto, T., Nakatani, A., Kataoka, Y., Houtani, T., Shirabe, S., et al. (1996). Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528-531.
34. Sakata, H., Takayama, H., Sharp, R., Rubin, J.S., Merlino, G., and LaRochelle, W.J. (1996). Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ. 7, 1513-1523.
35. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
36. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
37. Simson, J.A., Wang, J., Chao, J., and Chao, L. (1994). Histopathology of lymphatic tissues in transgenic mice expressing human tissue kallikrein gene. Lab. Invest. 71, 680-687.
38. Telling, G.G., Haga, T., Torchia, M., Tremblay, P., DeArmond, S.J., and Prusiner, S.B. (1996). Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 10, 1736-1750.
39. Tobler, I., Gaus, S.E., Deboer, T., Achermann, P., Fischer, M., Rülicke, T., Moser, M., Oesch, B., McBride, P.A., and Manson, J.C. (1996). Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639-642.
40. Weissmann, C. (1996). PrP effects clarified. Curr. Biol. 6, 1359.
41. Westaway, D., DeArmond, S.J., Cayetano, C.J., Groth, D., Foster, D., Yang, S.L., Torchia, M., Carlson, G.A., and Prusiner, S.B. (1994). Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76, 117-129.
42. Whittington, M.A., Sidle, K.C., Gowland, I., Meads, J., Hill, A.F., Palmer, M.S., Jefferys, J.G., and Collinge, J. (1995). Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat. Genet. 9, 197-201.
43. Wilmut, I., Hooper, M.L., and Simons, J.P. (1991). Genetic manipulation of mammals and its application in reproductive biology. J. Reprod. Fertil. 92, 245-279.
44. Yehiely, F., Bamborough, P., Da Costa, M., Perry, B.J., Thinakaran, G., Cohen, F.E., Carlson, G.A., and Prusiner, S.B. (1997). Identification of candidate proteins binding to prion protein. Neurobiol. Dis. 3, 339-355.
45. Xu, Z., Cork, L.C., Griffin, J.W., and Cleveland, D.W. (1993). Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell 73, 23-33.